The recent overhaul at STAAR, driven by an activist investor that resulted in the ousting of both the CEO and board chair, is more than just another headline in healthcare…
The announcement from CEO Dave Rosa about the da Vinci 5’s rollout outpacing expectations is a clear signal that Intuitive Surgical continues to dominate the surgical robotics market. However, the…
The evolving complexity of VA claims is not just a bureaucratic hurdle—it is a clarion call for healthcare and medical marketing professionals to rethink how we support veterans navigating this…
The so-called ‘Great Healthcare Plan’ is emblematic of a broader issue in healthcare policy communication: ambiguity that hinders strategic marketing and stakeholder engagement. For healthcare marketers, clarity is non-negotiable. This…
The current industry obsession with “strategic leadership” in healthcare risks becoming a buzzword devoid of actionable insight. While the article rightly positions leadership as central to progress, it stops short…
The recent guide on NovoRapid Vial’s use underscores a persistent challenge in diabetes management: bridging clinical efficacy with practical patient adherence. While NovoRapid’s fast-acting profile is well-known, the educational content…
Zylox-Tonbridge’s decision to acquire German medical technology company Optimed signals a bold, if somewhat risky, expansion strategy that deserves closer scrutiny from industry insiders. While cross-border acquisitions are not uncommon…
Epiminder’s announcement of the first US implantation of its Minder System signals a pivotal moment in the epilepsy device landscape. As an industry professional, it’s clear this isn’t just a…
The recent declaration by a medtech venture capital firm that kidney care is entering a new era of innovation is both timely and expected, but it warrants a critical lens.…
The tepid dealmaking observed at JPM26 should not be mistaken for stagnation in the healthcare sector. Instead, it highlights a deeper recalibration as pharmaceutical companies brace for the impending patent…